Updated:
Second Sight Medical Products
Second Sight Medical Products developed the Argus II bionic eye, the first FDA-approved retinal prosthesis; now merged with Nano Precision Medical.
Second Sight Medical Products
Second Sight Medical Products (Switzerland) Sarl (Switzerland) | 17 followers on LinkedIn.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
—
Corporate office
United States
Frequently asked questions
Who operates Second Sight Medical Products today?
Second Sight Medical Products merged with Nano Precision Medical in 2020 and operates as a combined entity. The executive team and board composition shifted post-merger; current leadership information is limited in public filings from recent years (per SEC filings).
What happened to the Argus II retinal prosthesis program?
The Argus II program continues to support existing implanted patients, but Second Sight paused development of the next-generation Orion cortical prosthesis in 2020 due to funding constraints. The company's current focus is on Nano Precision Medical's drug-delivery platform rather than new ophthalmic devices (per SEC filings and press releases, 2020).
Is Second Sight Medical Products still an operating medical device company?
Yes, but in a transformed form. Following the reverse merger with Nano Precision Medical, the combined entity is focused on drug delivery rather than visual prosthetics. The company's current operational status and pipeline are updated via SEC filings, which remain sparse since the merger (per public records).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: